Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determi-nation regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and pr...
Recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended...
<p>ACR: American College of Rheumatology, BSR: British society of rheumatology; EULAR: The European ...
Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), vari...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
American College of Rheumatology are intended to provide guidance for particular patterns of practic...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Disease modifying anti-rheumatic agents are the cornerstone in management of Rheumatoid Arthritis an...
ObjectiveTo develop updated guidelines for the pharmacologic management of rheumatoid arthritis.Meth...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended...
<p>ACR: American College of Rheumatology, BSR: British society of rheumatology; EULAR: The European ...
Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), vari...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
American College of Rheumatology are intended to provide guidance for particular patterns of practic...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Disease modifying anti-rheumatic agents are the cornerstone in management of Rheumatoid Arthritis an...
ObjectiveTo develop updated guidelines for the pharmacologic management of rheumatoid arthritis.Meth...
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (AC...
Recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended...
<p>ACR: American College of Rheumatology, BSR: British society of rheumatology; EULAR: The European ...
Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), vari...